Bioceltix S.A. (WSE:BCX)
89.70
-0.70 (-0.77%)
Jul 3, 2026, 5:00 PM CET
Bioceltix Employees
Bioceltix had 46 employees as of March 31, 2026. The number of employees increased by 11 or 31.43% compared to the same quarter last year.
Employees
46
Change
11
Growth
31.43%
Revenue / Employee
n/a
Profits / Employee
-370.50K PLN
Market Cap
496.24M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 46 | 11 | 31.43% |
| Dec 31, 2025 | 43 | 7 | 19.44% |
| Sep 30, 2025 | 41 | 14 | 51.85% |
| Jun 30, 2025 | 36 | 9 | 33.33% |
| Mar 31, 2025 | 35 | 8 | 29.63% |
| Dec 31, 2024 | 36 | 8 | 28.57% |
| Sep 30, 2024 | 27 | 1 | 3.85% |
| Mar 31, 2024 | 27 | 7 | 35.00% |
| Dec 31, 2023 | 28 | 8 | 40.00% |
| Sep 30, 2023 | 26 | 6 | 30.00% |
| Mar 31, 2023 | 20 | 6 | 39.96% |
| Dec 31, 2022 | 20 | 6 | 39.96% |
| Sep 30, 2022 | 20 | - | - |
| Mar 31, 2022 | 14 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BIOTON | 364 |
| Ryvu Therapeutics | 228 |
| Synthaverse | 214 |
| Mabion | 204 |
| Captor Therapeutics Spolka Akcyjna | 82 |
| Molecure | 71 |
| Urteste | 38 |
| Poltreg | 37 |
Bioceltix News
- 5 weeks ago - Bioceltix Quarterly report: Q1 2026 - Filings
- 2 months ago - Bioceltix Annual report: Q4 2025 - Filings
- 3 months ago - Bioceltix Slides: Company presentation - Filings
- 5 months ago - Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions - Business Wire
- 7 months ago - Bioceltix Quarterly report: Q3 2025 - Filings
- 9 months ago - 5 High Yield CEFs With Steep Discounts Right Now - Forbes
- 9 months ago - Bioceltix Quarterly report: Q2 2025 - Filings
- 10 months ago - Certain BlackRock Sector Equity Closed-End Funds Announce Updates to Investment Objectives and Principal Investment Strategies - Business Wire